• About
  • Advertise
  • Privacy & Policy
  • Contact
HK Businesswire
  • Home
  • News
    • All
    • Business
    • Politics
    • PR Newswire
    • Science
    • World
    ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma

    ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma

    Federation secures prestigious Victorian International Education Award wins

    Federation secures prestigious Victorian International Education Award wins

    Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others

    Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others

    RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) delivers statistically significant and clinically meaningful improvement in overall survival benefit for Asian patients with EGFR-mutated non-small cell lung cancer in the Phase 3 MARIPOSA study

    RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) delivers statistically significant and clinically meaningful improvement in overall survival benefit for Asian patients with EGFR-mutated non-small cell lung cancer in the Phase 3 MARIPOSA study

    TenPay Global and Mastercard collaborate to enable fast and secure remittances to Weixin Pay

    TenPay Global and Mastercard collaborate to enable fast and secure remittances to Weixin Pay

    Dulwich College Ranjit Murugason Sustainability Fund Secures Renewed Support from LGT Bank Singapore to Advance Student-Led Initiatives

    Dulwich College Ranjit Murugason Sustainability Fund Secures Renewed Support from LGT Bank Singapore to Advance Student-Led Initiatives

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • PR Newswire
  • Business
  • World
  • Entertainment
  • Sports
  • Tech
    • All
    • Apps
    • Gadget
    • Mobile
    • Startup

    Meituan Reports Q3 2025 Results: Revenue Reaches RMB95.5 Billion as Annual Transacting Users Surpass 800 Million

    Xiaomi Founder Lei Jun Boosts Stake as Company Ramps Up Buybacks, Signaling Confidence

    Ant Group’s Multimodal AI Assistant LingGuang Surpasses 1 Million Downloads in Four Days

    Xiaomi Produces 500,000th EV in Record Time, CEO Lei Jun Pledges Focus on Safety and Delivery

    Morrison Foerster Report: ESG Committees and Climate Policy Gaining Traction Among Asia’s Largest GPs

    Xiaomi’s Double 11 GMV Surges Past RMB 29 Billion as It Claims Top Domestic Phone Sales for Third Year

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
  • Feature
No Result
View All Result
  • Home
  • News
    • All
    • Business
    • Politics
    • PR Newswire
    • Science
    • World
    ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma

    ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma

    Federation secures prestigious Victorian International Education Award wins

    Federation secures prestigious Victorian International Education Award wins

    Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others

    Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others

    RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) delivers statistically significant and clinically meaningful improvement in overall survival benefit for Asian patients with EGFR-mutated non-small cell lung cancer in the Phase 3 MARIPOSA study

    RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) delivers statistically significant and clinically meaningful improvement in overall survival benefit for Asian patients with EGFR-mutated non-small cell lung cancer in the Phase 3 MARIPOSA study

    TenPay Global and Mastercard collaborate to enable fast and secure remittances to Weixin Pay

    TenPay Global and Mastercard collaborate to enable fast and secure remittances to Weixin Pay

    Dulwich College Ranjit Murugason Sustainability Fund Secures Renewed Support from LGT Bank Singapore to Advance Student-Led Initiatives

    Dulwich College Ranjit Murugason Sustainability Fund Secures Renewed Support from LGT Bank Singapore to Advance Student-Led Initiatives

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • PR Newswire
  • Business
  • World
  • Entertainment
  • Sports
  • Tech
    • All
    • Apps
    • Gadget
    • Mobile
    • Startup

    Meituan Reports Q3 2025 Results: Revenue Reaches RMB95.5 Billion as Annual Transacting Users Surpass 800 Million

    Xiaomi Founder Lei Jun Boosts Stake as Company Ramps Up Buybacks, Signaling Confidence

    Ant Group’s Multimodal AI Assistant LingGuang Surpasses 1 Million Downloads in Four Days

    Xiaomi Produces 500,000th EV in Record Time, CEO Lei Jun Pledges Focus on Safety and Delivery

    Morrison Foerster Report: ESG Committees and Climate Policy Gaining Traction Among Asia’s Largest GPs

    Xiaomi’s Double 11 GMV Surges Past RMB 29 Billion as It Claims Top Domestic Phone Sales for Third Year

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
  • Feature
No Result
View All Result
HK Businesswire
No Result
View All Result
Home News PR Newswire

Automex Debuts in Penang, Driving Malaysia’s Industry 5.0 Transformation

PR Newswire by PR Newswire
4 November 2025
in PR Newswire
0
Automex Debuts in Penang, Driving Malaysia’s Industry 5.0 Transformation
0
SHARES
14
VIEWS
Share on FacebookShare on Twitter

Malaysia’s leading automation and smart manufacturing exhibition unites 200+ global brands, featuring advanced robotics, automation, and smart factory innovations in the northern industrial hub.

GEORGE TOWN, Malaysia, Nov. 4, 2025 /PRNewswire/ — Malaysia’s leading automation and smart manufacturing exhibition, AUTOMEX, made its highly anticipated debut in Penang today, marking a transformative milestone in its 14-year legacy of driving the nation’s industrial evolution.

AUTOMEX DEBUTS IN PENANG, DRIVING MALAYSIA’S INDUSTRY 5.0 TRANSFORMATION
AUTOMEX DEBUTS IN PENANG, DRIVING MALAYSIA’S INDUSTRY 5.0 TRANSFORMATION

Organised by Informa Markets Malaysia, AUTOMEX Penang 2025 is running from 4–6 November at the Setia SPICE Convention Centre. The event was inaugurated by YB En Jagdeep Singh Deo, Deputy Chief Minister II of Penang, Dato’ Seri Wong Siew Hai, President of the Malaysia Semiconductor Industry Association (MSIA), and Gerard Leeuwenburgh, Country General Manager of Informa Markets Malaysia, ushering in a premier platform for innovation, collaboration, and the future of manufacturing technology.

Spanning 5,500 square meters, AUTOMEX Penang features more than 200 leading brands and companies showcasing the latest in robotics, industrial automation, and smart factory solutions, and is expected to attract over 5,000 trade visitors.

For over a decade, AUTOMEX has been held alongside METALTECH in Kuala Lumpur, establishing itself as Malaysia’s definitive platform for automation innovation. Its expansion to Penang reinforces both the state’s manufacturing growth and the government’s vision for Industry 4.0 – and signals a step toward Industry 5.0, where human creativity and technology work hand-in-hand.

“By bringing AUTOMEX to Penang, we’re not just expanding our footprint; we’re reaffirming our commitment to Malaysia’s manufacturing ecosystem,” said Gerard Leeuwenburgh, Country General Manager of Informa Markets Malaysia. “Penang is where innovation happens. From automation design and semiconductor production to smart manufacturing systems, this state embodies what AUTOMEX stands for: progress, partnership, and possibility.”

A key highlight of AUTOMEX Penang 2025 is its strategic collaboration with the Malaysia Semiconductor Industry Association (MSIA), elevating the event into a multi-dimensional platform for collaboration and innovation. MSIA, in partnership with Informa Markets, is organising the Silicon Malaysia Conference 2025 concurrently within the event, bringing together global leaders and innovators in the semiconductor and automation sectors to explore new frontiers in manufacturing technology.

“This collaboration bridges two of Malaysia’s most dynamic industries – automation and semiconductors,” said Gerard Leeuwenburgh. “By aligning these strengths, we’re creating opportunities for innovation and growth that will drive Malaysia’s competitiveness well into the future.”

“Our theme for the Silicon Malaysia Conference 2025 , ‘Made by Malaysia‘, reflects our ambition to lead, not only in what we manufacture, but in what we can design, develop, and imagine,” added Dato’ Seri Wong Siew Hai, President of MSIA.

AUTOMEX Penang 2025 supports the National Semiconductor Strategy (NSS) and the New Industrial Master Plan 2030 (NIMP 2030), which aim to transform Malaysia into a global hub for high-value, high-technology industries. These initiatives align closely with Penang2030, the state’s plan to become a Family-Focused, Green, and Smart State that Inspires the Nation.

Recognised as the Silicon Valley of the East, Penang contributes nearly 30% of Malaysia’s electrical and electronics (E&E) exports and hosts over 350 multinational corporations alongside thousands of SMEs. This robust industrial ecosystem – backed by strong policies and skilled talent – makes the state the natural choice for AUTOMEX’s expansion.

In 2024 alone, Penang attracted over RM30 billion in approved manufacturing investments, with global automation leaders such as M.A.i, KUKA Robotics, and HP Inc. continuing to invest and expand.

AUTOMEX Penang arrives at a pivotal moment in global manufacturing transformation. The global industrial automation market, valued at USD 178 billion in 2023, is projected to nearly double by 2031, signalling an unprecedented wave of technological adoption and industrial transformation.

At the heart of this evolution, AUTOMEX Penang connects people, ideas, and technologies – serving as a platform where local SMEs meet global technology providers and Malaysia’s manufacturing story continues to advance through shared expertise and innovation.

“Automation is not about replacing people – it is about empowering them,” said YB En Jagdeep Singh Deo, Deputy Chief Minister II of Penang. “It allows our workers to focus on creativity, design, and innovation – the very qualities that make Penang what it is today.”

In line with this vision, the Penang State Government has invested in Technical and Vocational Education and Training (TVET), upskilling programmes, and smart city infrastructure, preparing 150,000 Malaysians by 2030 for high-value roles in design, advanced packaging, and smart manufacturing. Green and sustainable development is a key priority, with initiatives including Batu Kawan Industrial Park 2, green-tech zones, and resilient water, energy, and digital infrastructure.

“Penang is not only ready for Industry 4.0 – we are shaping the future of Industry 5.0,” emphasised YB En Jagdeep Singh Deo. “What truly makes Malaysia and Penang stand out is collaboration. No one succeeds alone. The partnership between government, industry, and academia is what drives real change.”

Since its inception, AUTOMEX has evolved from a trade show into a strategic industry institution, where breakthroughs in robotics, AI, IoT, and smart manufacturing are showcased, and partnerships are forged. By connecting technology providers with local SMEs, multinational corporations, and talent, the exhibition accelerates Malaysia’s transformation into a high-tech, high-trust, human-centric manufacturing nation.

As productivity gains multiply and new opportunities emerge, AUTOMEX Penang is set to become a signature annual event for Malaysia’s automation community – a hub where technology meets talent, and where Penang continues to lead the nation’s manufacturing excellence.

“When history looks back at this decade, let it say that Malaysia dared to lead – not because we were the biggest or oldest, but because we were the boldest,” said Dato’ Seri Wong Siew Hai. 

The exhibition addresses the complete spectrum of attendee needs – from C-suite executives charting digital transformation strategies to engineers seeking specific technical solutions, procurement professionals evaluating supplier partnerships, students exploring robotics careers, and policymakers shaping Malaysia’s industrial future.

AUTOMEX Penang 2025 runs from 4–6 November 2025 at the Setia SPICE Convention Centre. For more information or to register, please visit www.automex.com.my.

Notes to Editors:

About AUTOMEX Penang

AUTOMEX Penang is Malaysia’s premier exhibition for automation, robotics, and smart manufacturing. Building on a 14-year co-location with METALTECH in Kuala Lumpur, the event expands into Penang – Malaysia’s “Silicon Valley of the East” and a global hub for semiconductors and advanced manufacturing. The exhibition showcases the latest innovations in robotics, machine vision, artificial intelligence (AI), the Internet of Things (IoT), and sustainable manufacturing solutions – connecting global technology providers with multinational corporations and SMEs. By attending, industry professionals gain access to cutting-edge solutions, strategic partnerships, and insights from thought leaders. AUTOMEX Penang empowers manufacturers, engineers, and decision-makers to accelerate digital transformation, enhance competitiveness, and capture growth opportunities across the global Industry 4.0 value chain.

Tags: prnewswire
PR Newswire

PR Newswire

PR Newswire is the industry’s leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world.

Read More

ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma

ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma

8 December 2025
Federation secures prestigious Victorian International Education Award wins

Federation secures prestigious Victorian International Education Award wins

8 December 2025
  • Trending
  • Comments
  • Latest
Tai Po fire death toll climbs to 44, 56 injured

Tai Po fire death toll climbs to 44, 56 injured

26 November 2025
No for now on women deacons, Vatican commission says

No for now on women deacons, Vatican commission says

4 December 2025

Ant Group’s Multimodal AI Assistant LingGuang Surpasses 1 Million Downloads in Four Days

23 November 2025
Hang Seng Indexes Company and Cyberport Partner to Drive Gen-AI Adoption in Index Calculation

Hang Seng Indexes Company and Cyberport Partner to Drive Gen-AI Adoption in Index Calculation

4 November 2025
ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma

ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma

8 December 2025
Federation secures prestigious Victorian International Education Award wins

Federation secures prestigious Victorian International Education Award wins

8 December 2025
Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others

Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others

8 December 2025
RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) delivers statistically significant and clinically meaningful improvement in overall survival benefit for Asian patients with EGFR-mutated non-small cell lung cancer in the Phase 3 MARIPOSA study

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) delivers statistically significant and clinically meaningful improvement in overall survival benefit for Asian patients with EGFR-mutated non-small cell lung cancer in the Phase 3 MARIPOSA study

8 December 2025

Recent News

ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma

ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma

8 December 2025
Federation secures prestigious Victorian International Education Award wins

Federation secures prestigious Victorian International Education Award wins

8 December 2025
Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others

Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others

8 December 2025
RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) delivers statistically significant and clinically meaningful improvement in overall survival benefit for Asian patients with EGFR-mutated non-small cell lung cancer in the Phase 3 MARIPOSA study

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) delivers statistically significant and clinically meaningful improvement in overall survival benefit for Asian patients with EGFR-mutated non-small cell lung cancer in the Phase 3 MARIPOSA study

8 December 2025
HK Businesswire

Stay ahead with the latest insights on Hong Kong’s economy, finance, and investments. From market trends to policy updates, we bring you in-depth analysis and expert opinions.

📩 Subscribe to our newsletter for exclusive updates.
📍 Follow us on social media for real-time news.
📧 Contact us: info@hongkong-invest.com

Follow Us

  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2025 by HKBusinesswire.com

No Result
View All Result

© 2025 by HKBusinesswire.com